Literature DB >> 22865049

IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells.

Zuoan Yi1, Li Li, Alaina Garland, Qiuming He, Haidong Wang, Jonathan D Katz, Roland Tisch, Bo Wang.   

Abstract

IFN-γ is generally believed to be important in the autoimmune pathogenesis of type 1 diabetes (T1D). However, the development of spontaneous β-cell autoimmunity is unaffected in NOD mice lacking expression of IFN-γ or the IFN-γ receptor (IFNγR), bringing into question the role IFN-γ has in T1D. In the current study, an adoptive transfer model was employed to define the contribution of IFN-γ in CD4(+) versus CD8(+) T cell-mediated β-cell autoimmunity. NOD.scid mice lacking expression of the IFNγR β chain (NOD.scid.IFNγRB(null)) developed diabetes following transfer of β cell-specific CD8(+) T cells alone. In contrast, β cell-specific CD4(+) T cells alone failed to induce diabetes despite significant infiltration of the islets in NOD.scid.IFNγRB(null) recipients. The lack of pathogenicity of CD4(+) T-cell effectors was due to the resistance of IFNγR-deficient β cells to inflammatory cytokine-induced cell death. On the other hand, CD4(+) T cells indirectly promoted β-cell destruction by providing help to CD8(+) T cells in NOD.scid.IFNγRB(null) recipients. These results demonstrate that IFN-γR may play a key role in CD4(+) T cell-mediated β-cell destruction.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865049      PMCID: PMC3883988          DOI: 10.1002/eji.201142374

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice.

Authors:  H T Kreuwel; J A Biggs; I M Pilip; E G Pamer; D Lo; L A Sherman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  IFN-gamma affects homing of diabetogenic T cells.

Authors:  A Y Savinov; F S Wong; A V Chervonsky
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 3.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

4.  IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.

Authors:  K Suk; S Kim; Y H Kim; K A Kim; I Chang; H Yagita; M Shong; M S Lee
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

5.  Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway.

Authors:  Won Ho Kim; June Woo Lee; Bin Gao; Myeong Ho Jung
Journal:  Cell Signal       Date:  2005-12       Impact factor: 4.315

6.  Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice.

Authors:  D V Serreze; C M Post; H D Chapman; E A Johnson; B Lu; P B Rothman
Journal:  Diabetes       Date:  2000-12       Impact factor: 9.461

7.  A novel direct competitive repopulation assay for human hematopoietic stem cells using NOD/SCID mice.

Authors:  T Tatekawa; H Ogawa; M Kawakami; Y Oka; K Yasukawa; H Sugiyama; I Kawase; T Soma
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 8.  Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self.

Authors:  Loredana Ruggeri; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

9.  The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse.

Authors:  F Nicoletti; P Zaccone; R Di Marco; M Di Mauro; G Magro; S Grasso; L Mughini; P Meroni; G Garotta
Journal:  Endocrinology       Date:  1996-12       Impact factor: 4.736

10.  Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells.

Authors:  E A Green; F S Wong; K Eshima; C Mora; R A Flavell
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  20 in total

1.  Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset.

Authors:  Susan J Burke; Michael D Karlstad; Adrianna E Eder; Kellie M Regal; Danhong Lu; David H Burk; J Jason Collier
Journal:  Biofactors       Date:  2016-06-21       Impact factor: 6.113

2.  Amelioration of type 1 diabetes by recombinant fructose-1,6-bisphosphate aldolase and cystatin derived from Schistosoma japonicum in a murine model.

Authors:  Ke Yan; Bo Wang; Huabang Zhou; Qingli Luo; Jilong Shen; Yunxia Xu; Zhengrong Zhong
Journal:  Parasitol Res       Date:  2019-12-16       Impact factor: 2.289

3.  Protein Glycosylation in Diabetes.

Authors:  Tamara Štambuk; Olga Gornik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

4.  Excessive Th1 responses due to the absence of TGF-β signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis.

Authors:  Harumichi Ishigame; Lauren A Zenewicz; Shomyseh Sanjabi; Paula Licona-Limón; Maki Nakayama; Warren J Leonard; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

Review 5.  Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy.

Authors:  Ludmila Rodrigues Pinto Ferreira; Amanda Farage Frade; Monique Andrade Baron; Isabela Cunha Navarro; Jorge Kalil; Christophe Chevillard; Edecio Cunha-Neto
Journal:  World J Cardiol       Date:  2014-08-26

Review 6.  CD4 T cell differentiation in type 1 diabetes.

Authors:  L S K Walker; M von Herrath
Journal:  Clin Exp Immunol       Date:  2015-07-28       Impact factor: 4.330

7.  The Impact of Diet Wheat Source on the Onset of Type 1 Diabetes Mellitus-Lessons Learned from the Non-Obese Diabetic (NOD) Mouse Model.

Authors:  Jonathan Gorelick; Ludmila Yarmolinsky; Arie Budovsky; Boris Khalfin; Joshua D Klein; Yosi Pinchasov; Maxim A Bushuev; Tatiana Rudchenko; Shimon Ben-Shabat
Journal:  Nutrients       Date:  2017-05-10       Impact factor: 5.717

8.  Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacity.

Authors:  Maja Wallberg; Asha Recino; Jenny Phillips; Duncan Howie; Margaux Vienne; Christopher Paluch; Miyuki Azuma; F Susan Wong; Herman Waldmann; Anne Cooke
Journal:  Immunology       Date:  2017-03-16       Impact factor: 7.397

9.  Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice.

Authors:  M Jubayer Rahman; Kameron B Rodrigues; Juan A Quiel; Yi Liu; Vipul Bhargava; Yongge Zhao; Chie Hotta-Iwamura; Han-Yu Shih; Annie W Lau-Kilby; Allison Mw Malloy; Timothy W Thoner; Kristin V Tarbell
Journal:  JCI Insight       Date:  2018-02-08

10.  PD-1 pathway-mediated regulation of islet-specific CD4+ T cell subsets in autoimmune diabetes.

Authors:  Tijana Martinov; Justin A Spanier; Kristen E Pauken; Brian T Fife
Journal:  Immunoendocrinology (Houst)       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.